Low plasma testosterone and elevated carotid intima-media thickness: Importance of low-grade inflammation in elderly men

Atherosclerosis

Volumn 223, Issue 1, 2012, Pages 244-249

  Soisson, Véronique ^a   Brailly Tabard, Sylvie ^b,c   Empana, Jean Philippe ^d   Féart, Catherine ^c,e   Ryan, Joanne ^f   Bertrand, Marion ^g   Guiochon Mantel, Anne ^b,c   Scarabin, Pierre Yves ^a  

^a CENTRE FOR RESEARCH IN EPIDEMIOLOGY AND POPULATION HEALTH   (France)

^b BICÊTRE HOSPITAL   (France)

^c INSERM   (France)

^d PARIS CARDIOVASCULAR RESEARCH CENTER   (France)

^e UNIVERSITÉ DE BORDEAUX   (France)

^f INSERM U1061   (France)

^g DIJON UNIVERSITY HOSPITAL   (France)

Author keywords

Atherosclerosis; C Reactive protein; Elderly men; Testosterone

Indexed keywords

C REACTIVE PROTEIN; ESTRADIOL; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

AGED; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR RISK; CAROTID ATHEROSCLEROSIS; COHORT ANALYSIS; CORRELATION ANALYSIS; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; TESTOSTERONE BLOOD LEVEL;

AGE FACTORS; AGED; AGED, 80 AND OVER; AGING; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CAROTID ARTERIES; CAROTID ARTERY DISEASES; CAROTID INTIMA-MEDIA THICKNESS; DOWN-REGULATION; ESTRADIOL; FRANCE; HUMANS; INFLAMMATION; LINEAR MODELS; MALE; MULTIVARIATE ANALYSIS; PLAQUE, ATHEROSCLEROTIC; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEX HORMONE-BINDING GLOBULIN; TESTOSTERONE;

EID: 84863094735     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2012.05.009     Document Type: Article

References (58)

1. Feldman H.A., Longcope C., Derby C.A., Johannes C.B., Araujo A.B., Coviello A.D., et al. Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study. The Journal of Clinical Endocrinology and Metabolism 2002, 87:589-598.
2. Jones T.H. Testosterone deficiency: a risk factor for cardiovascular disease?. Trends in Endocrinology and Metabolism: TEM 2010, 21:496-503.
3. Araujo A.B., Dixon J.M., Suarez E.A., Murad M.H., Guey L.T., Wittert G.A. Clinical review: endogenous testosterone and mortality in men: a systematic review and meta-analysis. The Journal of Clinical Endocrinology and Metabolism 2011, 96:3007-3019.
4. Ruige J.B., Mahmoud A.M., De Bacquer D., Kaufman J.M. Endogenous testosterone and cardiovascular disease in healthy men: a meta-analysis. Heart (British Cardiac Society) 2011.
5. Yeap B.B. Androgens and cardiovascular disease, Current opinion in endocrinology. Diabetes, and Obesity 2010, 17:269-276.
6. Barrett-Connor E., Khaw K.T. Endogenous sex hormones and cardiovascular disease in men. A prospective population-based study. Circulation 1988, 78:539-545.
7. Khaw K.T., Dowsett M., Folkerd E., Bingham S., Wareham N., Luben R., et al. Endogenous testosterone and mortality due to all causes, cardiovascular disease, and cancer in men: European prospective investigation into cancer in Norfolk (EPIC-Norfolk) prospective population study. Circulation 2007, 116:2694-2701.
8. Vikan T., Schirmer H., Njolstad I., Svartberg J. Endogenous sex hormones and the prospective association with cardiovascular disease and mortality in men: the Tromso study. European Journal of Endocrinology/European Federation of Endocrine Societies 2009, 161:435-442.
9. Svartberg J., von Muhlen D., Sundsfjord J., Jorde R. Waist circumference and testosterone levels in community dwelling men. The Tromso study. European Journal of Epidemiology 2004, 19:657-663.
10. Khaw K.T., Barrett-Connor E. Blood pressure and endogenous testosterone in men: an inverse relationship. Journal of Hypertension 1988, 6:329-332.
11. Khaw K.T., Barrett-Connor E. Endogenous sex hormones, high density lipoprotein cholesterol, and other lipoprotein fractions in men. Arteriosclerosis, Thrombosis and Vascular Biology 1991, 11:489-494.
12. Arnlov J., Pencina M.J., Amin S., Nam B.H., Benjamin E.J., Murabito J.M., et al. Endogenous sex hormones and cardiovascular disease incidence in men. Annals of Internal Medicine 2006, 145:176-184.
13. Smith G.D., Ben-Shlomo Y., Beswick A., Yarnell J., Lightman S., Elwood P. Cortisol, testosterone, and coronary heart disease: prospective evidence from the Caerphilly study. Circulation 2005, 112:332-340.
14. Ohlsson C., Barrett-Connor E., Bhasin S., Orwoll E., Labrie F., Karlsson M.K., et al. High serum testosterone is associated with reduced risk of cardiovascular events in elderly men. The MrOS (Osteoporotic fractures in men) study in Sweden. Journal of the American College of Cardiology 2011, 58:1674-1681.
15. Yeap B.B., Hyde Z., Almeida O.P., Norman P.E., Chubb S.A., Jamrozik K., et al. Lower testosterone levels predict incident stroke and transient ischemic attack in older men. The Journal of Clinical Endocrinology and Metabolism 2009, 94:2353-2359.
16. Salonen R., Salonen J.T. Determinants of carotid intima-media thickness: a population-based ultrasonography study in eastern Finnish men. Journal of Internal Medicine 1991, 229:225-231.
17. Svartberg J., von Muhlen D., Mathiesen E., Joakimsen O., Bonaa K.H., Stensland-Bugge E. Low testosterone levels are associated with carotid atherosclerosis in men. Journal of Internal Medicine 2006, 259:576-582.
18. De Pergola G., Pannacciulli N., Ciccone M., Tartagni M., Rizzon P., Giorgino R. Free testosterone plasma levels are negatively associated with the intima-media thickness of the common carotid artery in overweight and obese glucose-tolerant young adult men. International Journal of Obesity Related Metabolic Disorders 2003, 27:803-807.
19. Muller M., van den Beld A.W., Bots M.L., Grobbee D.E., Lamberts S.W., van der Schouw Y.T. Endogenous sex hormones and progression of carotid atherosclerosis in elderly men. Circulation 2004, 109:2074-2079.
20. Makinen J., Jarvisalo M.J., Pollanen P., Perheentupa A., Irjala K., Koskenvuo M., et al. Increased carotid atherosclerosis in andropausal middle-aged men. Journal of the American College of Cardiology 2005, 45:1603-1608.
21. 3C Study Group Vascular factors and risk of dementia: design of the Three-city study and baseline characteristics of the study population. Neuroepidemiology 2003, 22:316-325.
22. Carcaillon L., Alhenc-Gelas M., Bejot Y., Spaft C., Ducimetiere P., Ritchie K., et al. Increased thrombin generation is associated with acute ischemic stroke but not with coronary heart disease in the elderly: the Three-city cohort study. Arteriosclerosis, Thrombosis, and Vascular Biology 2011, 31:1445-1451.
23. Bland J.M., Altman D.G. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986, 1:307-310.
24. Loric S., Guechot J., Duron F., Aubert P., Giboudeau J. Determination of testosterone in serum not bound by sex-hormone-binding globulin: diagnostic value in hirsute women. Clinical Chemistry 1988, 34:1826-1829.
25. Straczek C., Ducimetiere P., Barberger-Gateau P., Helmer C., Ritchie K., Jouven X., et al. Higher level of systemic C-reactive protein is independently predictive of coronary heart disease in older community-dwelling adults: the three-city study. Journal of the American Geriatrics Society 2010, 58:129-135.
26. Zureik M., Gariepy J., Courbon D., Dartigues J.F., Ritchie K., Tzourio C., et al. Alcohol consumption and carotid artery structure in older French adults: the Three-City Study, Stroke. Journal of Cerebral Circulation 2004, 35:2770-2775.
27. Zureik M., Ducimetiere P., Touboul P.J., Courbon D., Bonithon-Kopp C., Berr C., et al. Common carotid intima-media thickness predicts occurrence of carotid atherosclerotic plaques: longitudinal results from the aging vascular study (EVA) study. Arteriosclerosis, Thrombosis, and Vascular Biology 2000, 20:1622-1629.
28. Blaha M.J., Rivera J.J., Budoff M.J., Blankstein R., Agatston A., O'Leary D.H., et al. Association between obesity, high-sensitivity C-reactive protein >/=2 mg/L, and subclinical atherosclerosis: implications of JUPITER from the Multi-Ethnic Study of Atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology 2011, 31:1430-1438.
29. Hak A.E., Witteman J.C., de Jong F.H., Geerlings M.I., Hofman A., et al. Low levels of endogenous androgens increase the risk of atherosclerosis in elderly men: the Rotterdam study. The Journal of Clinical Endocrinology and Metabolism 2002, 87:3632-3639.
30. Tivesten A., Mellstrom D., Jutberger H., Fagerberg B., Lernfelt B., Orwoll E., et al. Low serum testosterone and high serum estradiol associate with lower extremity peripheral arterial disease in elderly men. The MrOS study in Sweden. Journal of the American College of Cardiology 2007, 50:1070-1076.
31. Vikan T., Johnsen S.H., Schirmer H., Njolstad I., Svartberg J. Endogenous testosterone and the prospective association with carotid atherosclerosis in men: the Tromso study. European Journal of Epidemiology 2009, 24:289-295.
32. van den Beld A.W., Bots M.L., Janssen J.A., Pols H.A., Lamberts S.W., Grobbee D.E. Endogenous hormones and carotid atherosclerosis in elderly men. American Journal of Epidemiology 2003, 157:25-31.
33. Dorr M., Wallaschofski H., Friedrich N. Association of low total testosterone levels and prevalent carotid plaques: result of the study of health in Pomerania. European Journal of Epidemiology 2009, 24:389-391.
34. Spence J.D., Rundek T. Toward clinical Applications of carotid ultrasound: intima-media thickness, plaque area, and three-dimensional phenotypes. Ultrasound and carotid bifurcation atherosclerosis 2012, Springer. A. Nicolaides (Ed.).
35. Inaba Y., Chen J.A., Bergmann S.R. Carotid plaque, compared with carotid intima-media thickness, more accurately predicts coronary artery disease events: a meta-analysis. Atherosclerosis 2012, 220:128-133.
36. Plichart M., Celermajer D.S., Zureik M., Helmer C., Jouven X., Ritchie K., et al. Carotid intima-media thickness in plaque-free site, carotid plaques and coronary heart disease risk prediction in older adults. The three-city study. Atherosclerosis 2011, 219:917-924.
37. Dai W.S., Kuller L.H., LaPorte R.E., Gutai J.P., Falvo-Gerard L., Caggiula A. The epidemiology of plasma testosterone levels in middle-aged men. American Journal of Epidemiology 1981, 114:804-816.
38. Liu P.Y., Death A.K., Handelsman D.J. Androgens and cardiovascular disease. Endocrine Reviews 2003, 24:313-340.
39. Fukui M., Kitagawa Y., Kamiuchi K., Hasegawa G., Yoshikawa T., Nakamura N. Association between serum estradiol concentrations and carotid atherosclerosis in men with type 2 diabetes mellitus. Metabolism: Clinical and Experimental 2008, 57:285-289.
40. Tivesten A., Hulthe J., Wallenfeldt K., Wikstrand J., Ohlsson C., Fagerberg B. Circulating estradiol is an independent predictor of progression of carotid artery intima-media thickness in middle-aged men. The Journal of Clinical Endocrinology and Metabolism 2006, 91:4433-4437.
41. Hyde Z., Norman P.E., Flicker L., Hankey G.J., Almeida O.P., McCaul K.A., et al. Low free testosterone predicts mortality from cardiovascular disease but not other causes: the health in men study. The Journal of Clinical Endocrinology and Metabolism 2012.
42. Kaptoge S., Di Angelantonio E., Lowe G., Pepys M.B., Thompson S.G., Collins R., et al. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet 2010, 375:132-140.
43. Cao J.J., Arnold A.M., Manolio T.A., Polak J.F., Psaty B.M., Hirsch C.H., et al. Association of carotid artery intima-media thickness, plaques, and C-reactive protein with future cardiovascular disease and all-cause mortality: the cardiovascular health study. Circulation 2007, 116:32-38.
44. Jones T.H., Saad F. The effects of testosterone on risk factors for, and the mediators of, the atherosclerotic process. Atherosclerosis 2009, 207:318-327.
45. Kupelian V., Chiu G.R., Araujo A.B., Williams R.E., Clark R.V., McKinlay J.B. Association of sex hormones and C-reactive protein levels in men. Clinical Endocrinology 2010, 72:527-533.
46. Laughlin G.A., Barrett-Connor E., Bergstrom J. Low serum testosterone and mortality in older men. The Journal of Clinical Endocrinology and Metabolism 2008, 93:68-75.
47. Nakhai Pour H.R., Grobbee D.E., Muller M., van der Schouw Y.T. Association of endogenous sex hormone with C-reactive protein levels in middle-aged and elderly men. Clinical Endocrinology 2007, 66:394-398.
48. Bonithon-Kopp C., Scarabin P.Y., Bara L., Castanier M., Jacqueson A., Roger M. Relationship between sex hormones and haemostatic factors in healthy middle-aged men. Atherosclerosis 1988, 71:71-76.
49. Caron P., Bennet A., Camare R., Louvet J.P., Boneu B., Sie P. Plasminogen activator inhibitor in plasma is related to testosterone in men. Metabolism: Clinical and Experimental 1989, 38:1010-1015.
50. Yang X.C., Jing T.Y., Resnick L.M., Phillips G.B. Relation of hemostatic risk factors to other risk factors for coronary heart disease and to sex hormones in men. Arteriosclerosis, Thrombosis, and Vascular Biology 1993, 13:467-471.
51. Borissoff J.I., Spronk H.M., ten Cate H. The hemostatic system as a modulator of atherosclerosis. The New England Journal of Medicine 2011, 364:1746-1760.
52. Yudkin J.S. Inflammation, obesity, and the metabolic syndrome. Hormone and Metabolic Research/Hormon- und Stoffwechselforschung/Hormones Et Metabolisme 2007, 39:707-709.
53. Blouin K., Boivin A., Tchernof A. Androgens and body fat distribution. The Journal of Steroid Biochemistry and Molecular Biology 2008, 108:272-280.
54. Alessi M.C., Poggi M., Juhan-Vague I. Plasminogen activator inhibitor-1, adipose tissue and insulin resistance. Current Opinion in Lipidology 2007, 18:240-245.
55. Rosner W., Auchus R.J., Azziz R., Sluss P.M., Raff H. Position statement: utility, limitations, and pitfalls in measuring testosterone: an endocrine society position statement. The Journal of Clinical Endocrinology and Metabolism 2007, 92:405-413.
56. Matsumoto A.M., Bremner W.J. Serum testosterone assays-accuracy matters. The Journal of Clinical Endocrinology and Metabolism 2004, 89:520-524.
57. Toniolo P., Lukanova A. The challenge of measuring circulating estradiol at low concentrations. Breast Cancer Research 2005, 7:45-47.
58. Brambilla D.J., Matsumoto A.M., Araujo A.B., McKinlay J.B. The effect of diurnal variation on clinical measurement of serum testosterone and other sex hormone levels in men. The Journal of Clinical Endocrinology and Metabolism 2009, 94:907-913.